Description
Syndol Tablets offer comprehensive pain relief, specifically formulated to alleviate tension headaches, migraines, and muscle pain. Combining paracetamol, codeine, caffeine, and doxylamine, Syndol provides a potent solution for those experiencing intense pain or headaches related to stress and muscle tension. This unique blend not only targets pain but also promotes relaxation, helping to relieve associated symptoms like muscle stiffness and stress-induced headaches.
Key Features:
- Active Ingredients: Paracetamol (450mg), Codeine Phosphate (10mg), Caffeine (30mg), Doxylamine Succinate (5mg) per tablet
- Dual-action Relief: Reduces pain while helping to relax muscles and ease tension.
- Purpose: Effective for tension headaches, migraines, muscle pain, and moderate pain relief.
- Suitable For: Adults and children aged 12 years and over.
Directions for Use
- Dosage: Adults and children over 12 years: Take 1-2 tablets every 4 to 6 hours as needed. Do not exceed 8 tablets in 24 hours.
- Usage Note: Tablets should be swallowed with water, avoiding alcohol while taking this medicine.
Ingredients
- Active: Paracetamol, Codeine Phosphate, Caffeine, Doxylamine Succinate.
- Other Ingredients: Lactose monohydrate, maize starch, stearic acid, and magnesium stearate. Refer to packaging for full ingredient details.
Possible Side Effects
Side effects are uncommon but may include:
- Drowsiness, dizziness, or blurred vision
- Nausea or upset stomach
- Allergic reactions (e.g., rash, itching)
- Constipation due to codeine
If you experience severe side effects or unusual symptoms, stop using Syndol and consult a healthcare provider.
Important Warnings
- Dependency: Codeine may be habit-forming; avoid prolonged use without medical supervision.
- Do Not Exceed the stated dose; excessive use can lead to liver damage.
- Avoid Driving if feeling drowsy or dizzy after taking Syndol.
- Pregnancy and Breastfeeding: Avoid use during pregnancy and breastfeeding; seek professional advice if unsure.
For additional safety information, please consult the patient information leaflet provided.